CatalystPit

VNRXVOLITIONRX LTD

AMEX · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Last close $0.26 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market cap$3.52M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-30 · Michel Gaetan (Chief Operating Officer) · OTHER
  • 2026-09-30 · Forterre Gael (Chief Commercial Officer) · OTHER
  • 2026-03-19 · Rootsaert Rodney Gerard (Secretary) · OTHER
  • 2026-03-19 · Micallef Jacob Vincent (Chief Scientific Officer) · OTHER
  • 2026-03-19 · Forterre Gael (Chief Commercial Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders26
Shares held3,976,213
Value$3.31M
Percent of shares outstanding29.13%
As of quarter end2026-06-30
RECENT NEWS
  • VolitionRx shares details on DETECSEPS program launch in France
  • VolitionRx selected for France's sepsis detection program
  • VolitionRx issues shares for note conversions, updates share count
  • VolitionRx prepays $7.5M senior secured convertible note
  • VolitionRx prepays $7.5 million senior secured convertible note in full
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
VOLITIONRX LTD (VNRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit